Mr. Redmond has over twenty years of global experience in the bio-pharmaceutical industry both in the public and private sectors. His experience includes product management & commercialisation, marketing management, patient advocacy, and global account management including Sanofi-Aventis, BMS, Novartis, INO Therapeutics (now Ikaria in the US & Linde Gas Therapeutics in Europe), Quintiles, Havas Life, and Lowe Healthcare Worldwide. He has a solid understanding of market and investment trends and how to navigate through the complexities of market access.
His career in the industry began at the National Institutes of Health in the Department of Transfusion Medicine working in the Clinical Research Center and for the NIH Marrow Donor Program. Amongst his responsibilities, Mr. Redmond was responsible for public affairs, patient advocacy, and management of U.S. government grants for HLA testing, while leading negotiations of collaborative research and development agreements. During his tenure at the NIH, Mr. Redmond was president of a foundation which secured funding for bone marrow typing.
Mr. Redmond has expanded his expertise in the non-profit industry by advocating for a variety of
Mr. Redmond has over twenty years of global experience in the bio-pharmaceutical industry both in the public and private sectors. His experience includes product management & commercialisation, marketing management, patient advocacy, and global account management including Sanofi-Aventis, BMS, Novartis, INO Therapeutics (now Ikaria in the US & Linde Gas Therapeutics in Europe), Quintiles, Havas Life, and Lowe Healthcare Worldwide. He has a solid understanding of market and investment trends and how to navigate through the complexities of market access.
His career in the industry began at the National Institutes of Health in the Department of Transfusion Medicine working in the Clinical Research Center and for the NIH Marrow Donor Program. Amongst his responsibilities, Mr. Redmond was responsible for public affairs, patient advocacy, and management of U.S. government grants for HLA testing, while leading negotiations of collaborative research and development agreements. During his tenure at the NIH, Mr. Redmond was president of a foundation which secured funding for bone marrow typing.
Mr. Redmond has expanded his expertise in the non-profit industry by advocating for a variety of important issues ranging from healthcare to international corporate expansion to cross-border taxation challenges. He has worked with high level officials in the US and French governments as well as on the European level.
Because of his multi-cultural experience, Mr. Redmond instructs senior executives on team management amongst different cultures/countries in order to facilitate business and maximise productivity. He has been a guest speaker/commentator with a variety of international media outlets on topics including global healthcare and international taxation.
Mr. Redmond is a dual American/French national who was educated in the United States. He is a member of Association of Americans Resident Overseas and is on the board of directors for Republicans Overseas France. He currently resides in Paris, France.
